Product
Bacillus Calmette Guerin
Aliases
BCG
3 clinical trials
4 indications
Indication
Adverse Drug ReactionIndication
Bladder CancerIndication
Mycobacterium bovis BCGIndication
Non-muscle-invasive Bladder CancerClinical trial
Nordic Urothelial Cancer Research Group Study on Reduced BCG Dwell-Time in High Risk NMIBCStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Systemic Immunological Response of Bladder Cancer Patients Under Bacillus Calmette Guérin TreatmentStatus: , Estimated PCD: 2026-12-18
Clinical trial
A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE)Status: Recruiting, Estimated PCD: 2029-11-01